Page last updated: 2024-08-23

daunorubicin and Granulocytic Leukemia, Chronic

daunorubicin has been researched along with Granulocytic Leukemia, Chronic in 67 studies

Research

Studies (67)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (5.97)	18.7374
1990's	35 (52.24)	18.2507
2000's	15 (22.39)	29.6817
2010's	11 (16.42)	24.3611
2020's	2 (2.99)	2.80

Authors

Authors	Studies
Chang, LS; Chiou, JT; Huang, CH; Huang, PW; Lee, YC; Wang, LJ; Wu, TH	1
Cañedo, AD; Lettnin, AP; Rumjanek, VM; Salgado, MTSF; Trindade, GS; Votto, APS; Wagner, EF	1
Akram, M; Quraishi, AM; Saeed, S; Tahir, M	1
Chen, Y; He, Y; Huang, R; Kang, Q; Li, Y; Liu, H; Tu, S; Wang, L; Wu, A; Yang, J; Zhou, X	1
He, Y; Hu, Y; Li, XD; Lin, DJ; Wang, DN; Wang, WW; Xiao, RZ	1
Bukvova, R; Dolezel, P; Kosztyu, P; Mlejnek, P	1
Bian, C; Dong, Y; Hu, X; Jiang, Y; Liu, Z; Ma, C; Wang, Y	1
Bydlowski, SP; Cavaglieri, RC; Domont, G; Nogueira, FC; Palmisano, G; Rosa Fernandes, L; Stern, AC	1
Bao, W; Chen, BA; Chen, N; Chen, W; Cheng, J; Ding, J; Gao, C; Gao, F; Li, X; Liu, L; Song, H; Sun, X; Sun, Y; Wang, X; Wu, W; Xia, G; Xu, C; Xu, W	1
Ohno, R	1
Gui-Nan, L; Guo-Bao, W; Jie, L; Qi-Rong, G; Xiao-Qin, C; Yue, L	1
Berthou, C; Castaigne, S; Cayuela, JM; Cony-Makhoul, P; Deau, B; Gardembas, M; Guerci, A; Guilhot, F; Guilhot, J; Guyotat, D; Hayette, S; Huguet, F; Legros, L; Mahon, FX; Michallet, M; Nicolini, FE; Pautas, C; Réa, D; Rousselot, P; Weiss, IR	1
Dolezel, P; Kocurova, A; Krumpochova, P; Mlejnek, P	1
Chen, X; Yang, W; Zhu, X	1
Bao, W; Cai, X; Chen, B; Cheng, J; Ding, J; Gao, C; Liu, R; Ren, Y; Song, H; Tian, L; Wang, J; Wang, L; Wang, S; Wang, X; Wu, W; Xia, G; Zhang, H	1
Brandwein, J; Gupta, V; Kamel-Reid, S; Lipton, JH; Messner, HA; Minden, MD	1
Kimura, S; Kuroda, J; Maekawa, T; Nogawa, M; Ottmann, OG; Sato, K; Segawa, H; Yuasa, T	1
Ascani, S; Bonomini, S; Caramatti, C; Colla, S; Craviotto, L; Crugnola, M; De Celis, I; Giuliani, N; Hojden, M; Morandi, F; Rizzoli, V; Sabbatini, E; Sammarelli, G	1
Balleari, E; Ballerini, F; Balocco, M; Canepa, L; Clavio, M; Garrone, A; Gobbi, M; Michelis, GL; Miglino, M; Pierri, I; Venturino, C	1
Galski, H; Lazarovici, P; Nagler, A; Sivan, H	1
Mahadevan, D	1
Aleskog, A; Barbany, G; Bengtsson, M; Björnberg, A; Höglund, M; Larsson, R; Lindhagen, E; Olsson-Strömberg, U; Simonsson, B	1
Alsop, S; Elenitoba-Johnson, KS; Lim, MS; Sanger, WG	1
Kouides, PA; Rowe, JM	1
Endo, T; Fukumaki, Y; Ishibashi, Y; Okano, H; Shiokawa, S	1
Kurokawa, H; Nagata, K; Nara, N; Tanikawa, S; Tohda, S; Tomiyama, J	1
Efferth, T; Fabry, U; Glatte, P; Osieka, R	1
Calvert, L; Claxton, D; Durett, A; Giralt, S; Hamer, J; Kantarjian, H; Khouri, I; Liang, J; Talpaz, M; Tibbits, P	1
Calvert, L; Deisseroth, AB; Feldman, E; Hester, J; Kantarjian, HM; Korbling, M; Liang, J; Rios, MB; Smith, TL; Talpaz, M	1
Andreeff, M; Godfrey, L; Hegewisch-Becker, S; Maslak, P	1
Ambrosetti, A; Aprili, F; Krampera, M; Martinelli, G; Meneghini, V; Perona, G; Pizzolo, G; Veneri, D	1
Kantarjian, HM; Talpaz, M	1
Harbott, J; Lampert, F; Li, L; Lohmeyer, J; Pralle, H; Ritterbach, J; Schroyens, W	1
Goldman, J; Morleda, J; Mughal, T	1
Hashimoto, S; Shibata, A	1
Ahmad, PA; Ahmed, S; Anwar, M; Mushtaq, S; Saleem, M; Siddiqui, SA	1
Baccarani, M; Damiani, D; Fanin, R; Michelutti, A; Michieli, M; Russo, D	1
Kuyama, J; Take, H	1
Grahn, MF; Jia, L; Jiang, XR; Kelsey, SM; Newland, AC	1
Bartram, CR; Borkhardt, A; Harbott, J; Janka-Schaub, G; Janssen, JW; Kabisch, H; Lampert, F; Ludwig, WD; Ratei, R; Reinisch, I; Repp, R; Riehm, H; Ritterbach, J; Schlieben, S; Schrappe, M; Zimmermann, M	1
Caron, PC; Curcio, M; Mechetner, EB; Raghu, G; Roepe, PD; Scheinberg, DA; Weisburg, JH	1
Alpdoğan, O; Alpdoğan, TB; Bayik, M; Demirçay, Z; Gürbüz, O; Kurtkaya, O; Yücelten, D	1
Niewint, AW; Ossenkoppele, GJ; Schuurhuis, GJ; Theijsmeijer, AP; Thijsen, SF; van Oostveen, JW	1
Audisio, E; Chiusa, L; Marmont, F; Pich, A	1
Badri, N; Boogaerts, M; Carella, AM; Dabouz-Harrouche, F; Gautier, L; Gorin, NC; Lennard, A; Link, H; Simonsson, B; Tomas-Martinez, JF	1
Conn, JS; Dickinson, AM; Irving, JA; Lennard, A; Proctor, SJ; Rowe, D; Storey, N	1
Elgie, AW; Lewandowicz, GM; Sargent, JM; Taylor, CG; Williamson, CJ	1
Cortes, J; Estey, E; Giles, F; Kantarjian, H; Keating, M; O'Brien, S	1
Mandelli, F; Montefusco, E	1
Esche, H; Opalka, B; Parssanedjad, K; Pützer, BM; Stiewe, T	1
Baggio, G; Casolari, C; Castelli, M; Cermelli, C; Lupo, L; Malagoli, M; Riccomi, TR; Zanca, A	1
Beran, M; Cortes, J; Giles, FJ; Kantarjian, H; Keating, M; Koller, C; O'Brien, S; Rios, MB; Talpaz, M	1
Dan, K; Inami, M; Inokuchi, K; Miyata, J; Tajika, K; Watanabe, A; Yamaguchi, H; Yokomizo, E	1
Belloc, F; Berthaud, P; Cony Makhoul, P; Lacombe, F; Lagarde, V; Mahon, FX; Melo, JV; Reiffers, J; Tabrizi, R	1
Jastrzebska, M; Lukowska, K; Pacholska, J; Paciorkiewicz, W; Rokicka-Milewska, R	1
Kawakubo, K; Ohto, T; Ohyashiki, JH; Ohyashiki, K; Tauchi, T; Toyama, K	1
Cao, LX; Chen, H; Zeng, TQ	1
Beran, M; Deisseroth, A; Estey, EH; Gutterman, J; Kantarjian, HM; Keating, MJ; Kontoyiannis, D; O'Brien, S; Rios, MB; Talpaz, M	1
Beran, M; Estey, EH; Freireich, EJ; Gutterman, J; Kantarjian, HM; Keating, MJ; McCredie, KB; O'Brien, S; Talpaz, M	1
Bungo, M; Fourcade, A; Horichi, N; Kasahara, K; Lampidis, TJ; Nishiyama, M; Sasaki, Y; Sugimoto, Y; Takahashi, T; Tapiero, H	1
Arai, N; Shirai, T; Umeda, M	1
Festa, RS; Lanzkowsky, P; Shende, A	1
Anger, B; Heimpel, H	1
Maruyama, Y; Nagata, K; Nakamura, S; Onozawa, Y; Sakamaki, H; Yahara, Y	1
Andreeff, M; Berman, E; Clarkson, BD; Gabrilove, J; Gee, TS; Gulati, S; Kempin, SJ; Raymond, V; Wiernik, PH; Young, CW	1
Andreeff, M; Berman, E; Gabrilove, J; Gee, T; Gulati, S; Heller, G; Kempin, SJ; Kolitz, J; Raymond, V; Young, CW	1

Reviews

6 review(s) available for daunorubicin and Granulocytic Leukemia, Chronic

Article	Year
Treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy. Current hematologic malignancy reports, 2006, Volume: 1, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Multicenter Studies as Topic; Piperazines; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Remission Induction; Survival Rate; Vincristine	2006
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia. European journal of haematology, 2004, Volume: 72, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Burkitt Lymphoma; Cytarabine; Daunorubicin; Female; Humans; Imatinib Mesylate; Immunophenotyping; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Piperazines; Pyrimidines; Remission Induction	2004
[Interferon therapy for chronic myelogenous leukemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Hydroxyurea; Immunity, Cellular; Interferon-alpha; Interferon-gamma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; T-Lymphocytes; Vincristine	1993
[Treatment of acute and chronic leukemias]. Recenti progressi in medicina, 1999, Volume: 90, Issue:11 Topics: Acute Disease; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosome Aberrations; Combined Modality Therapy; Daunorubicin; Humans; Idarubicin; Karyotyping; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Transplantation, Autologous; Transplantation, Homologous	1999
Philadelphia chromosome-positive acute myeloid leukemia with tetraploidy. International journal of hematology, 2002, Volume: 75, Issue:1 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Daunorubicin; Fusion Proteins, bcr-abl; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Polyploidy; Prednisolone; Remission Induction; RNA, Messenger; RNA, Neoplasm	2002
[Chronic myelocytic leukemia following chemotherapy of acute promyelocytic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:11 Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisolone; Remission Induction	1989

Trials

10 trial(s) available for daunorubicin and Granulocytic Leukemia, Chronic

Article	Year
The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study). Leukemia research, 2011, Volume: 35, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Combined Modality Therapy; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Exanthema; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neutropenia; Piperazines; Prospective Studies; Pyrimidines; Survival Analysis; Treatment Outcome; Young Adult	2011
Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia. Annals of hematology, 2004, Volume: 83, Issue:11 Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Factors; Survival Rate; Vidarabine	2004
Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center. Leukemia & lymphoma, 1993, Volume: 11 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Daunorubicin; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxyurea; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Interferon-gamma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Life Tables; Prednisone; Recombinant Proteins; Remission Induction; Survival Analysis; Texas; Treatment Outcome; Vincristine	1993
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Leukemia, 1996, Volume: 10, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Base Sequence; Child; Child, Preschool; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Fusion Proteins, bcr-abl; Germany; Humans; Incidence; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mercaptopurine; Methotrexate; Molecular Sequence Data; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Transcription, Genetic; Translocation, Genetic; Vincristine	1996
Nucleolar organizer region counts predict complete remission, remission duration, and survival in adult acute myelogenous leukemia patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:4 Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Cell Division; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nucleolus Organizer Region; Predictive Value of Tests; Prognosis; Remission Induction; Survival Rate	1998
Collection of Philadelphia-negative peripheral blood progenitor cells in unselected patients with chronic granulocytic leukaemia. Northern Regional Haematology Group. Leukemia, 1998, Volume: 12, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Female; Fusion Proteins, bcr-abl; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Philadelphia Chromosome; Pilot Projects; Vincristine	1998
Phase I study of liposomal daunorubicin in patients with acute leukemia. Investigational new drugs, 1999, Volume: 17, Issue:1 Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Dose-Response Relationship, Drug; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Liposomes; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence	1999
Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase. Leukemia & lymphoma, 2001, Volume: 41, Issue:3-4 Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Cytarabine; Cytogenetic Analysis; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prednisolone; Prednisone; Risk Factors; Survival Rate; Therapeutic Equivalency; Treatment Outcome; Vincristine	2001
Idarubicin in acute leukemia: results of US trials. Bone marrow transplantation, 1989, Volume: 4 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Humans; Idarubicin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute	1989
Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center. Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction	1989

Other Studies

51 other study(ies) available for daunorubicin and Granulocytic Leukemia, Chronic

Article	Year
CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells. Toxicology and applied pharmacology, 2022, 01-15, Volume: 435 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Daunorubicin; Drug Synergism; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; Myeloid Cell Leukemia Sequence 1 Protein; NADPH Oxidase 4; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Sp1 Transcription Factor; Sulfonamides	2022
Multidrug resistance phenotype and its relation to stem cell characteristics in chronic myeloid leukemia. Gene, 2024, Jan-20, Volume: 892 Topics: Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phenotype; Stem Cells	2024
Philadelphia Chromosome Positive de novo Acute Myeloid Leukemia. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2016, Volume: 26, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Philadelphia Chromosome; Rare Diseases; Recurrence; Remission Induction; Treatment Outcome; Young Adult	2016
EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway. Oncology reports, 2018, Volume: 39, Issue:1 Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Female; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Up-Regulation	2018
Acute pleural and pericardial effusion induced by chemotherapy in treating chronic myelocytic leukemia. Clinical laboratory, 2014, Volume: 60, Issue:5 Topics: Adult; Antineoplastic Agents; Cytarabine; Daunorubicin; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pericardial Effusion; Pleural Effusion	2014
Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cells. Chemico-biological interactions, 2014, Aug-05, Volume: 219 Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blotting, Western; Cell Survival; Daunorubicin; Drug Resistance, Neoplasm; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Proteins; Piperazines; Pyrimidines	2014
Overexpression of Hiwi Inhibits the Cell Growth of Chronic Myeloid Leukemia K562 Cells and Enhances Their Chemosensitivity to Daunomycin. Cell biochemistry and biophysics, 2015, Volume: 73, Issue:1 Topics: Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Argonaute Proteins; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Resistance, Neoplasm; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2015
7-Ketocholesterol overcomes drug resistance in chronic myeloid leukemia cell lines beyond MDR1 mechanism. Journal of proteomics, 2017, 01-16, Volume: 151 Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Cycle Checkpoints; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Ketocholesterols; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Proteomics; Proteostasis Deficiencies; Vincristine	2017
Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells. International journal of nanomedicine, 2009, Volume: 4 Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Benzylisoquinolines; Cell Survival; Daunorubicin; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Ferrosoferric Oxide; Genes, MDR; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetics; Metal Nanoparticles; Nanomedicine; RNA, Messenger; RNA, Neoplasm	2009
Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of beta(1)-integrin in K562 chronic myelogenous leukemia cell line. Leukemia & lymphoma, 2010, Volume: 51, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Bone Marrow Cells; Cell Adhesion; Cell Survival; Cells, Cultured; Coculture Techniques; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Humans; Inhibitory Concentration 50; Integrin beta1; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oxides; Stromal Cells	2010
Assay for determination of daunorubicin in cancer cells with multidrug resistance phenotype. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Jul-01, Volume: 879, Issue:21 Topics: Antibiotics, Antineoplastic; Daunorubicin; DNA, Neoplasm; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescence; Humans; Intracellular Space; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Linear Models; Sensitivity and Specificity	2011
Successful treatment of childhood Philadelphia chromosome-positive acute myeloid leukemia. Pediatrics international : official journal of the Japan Pediatric Society, 2011, Volume: 53, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Child; Cytarabine; Daunorubicin; Female; Harringtonines; Homoharringtonine; Humans; Imatinib Mesylate; Induction Chemotherapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Maintenance Chemotherapy; Piperazines; Pyrimidines	2011
Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance. International journal of nanomedicine, 2012, Volume: 7 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; Benzylisoquinolines; Caspase 3; Combined Modality Therapy; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Hyperthermia, Induced; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Field Therapy; Magnetite Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays	2012
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias. Hematology (Amsterdam, Netherlands), 2003, Volume: 8, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Cytarabine; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Female; Fusion Proteins, bcr-abl; Hepatitis B; Humans; Imatinib Mesylate; Immunosuppressive Agents; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Remission Induction; Salvage Therapy; Vincristine	2003
Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines. International journal of hematology, 2004, Volume: 79, Issue:1 Topics: Antineoplastic Agents; Benzamides; Cell Death; Cell Division; Cell Line, Tumor; Cytarabine; Daunorubicin; Diphosphonates; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Hydroxyurea; Imatinib Mesylate; Imidazoles; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Piperazines; Pyrimidines; Vincristine; Zoledronic Acid	2004
In vitro and in vivo reversal of MDR1-mediated multidrug resistance by KT-5720: implications on hematological malignancies. Leukemia research, 2006, Volume: 30, Issue:9 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Carbazoles; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Mice, Transgenic; Multiple Myeloma; Pyrroles	2006
Will MDR-1/P-gp modulators provide clinical benefit in hematologic malignancies? Leukemia research, 2006, Volume: 30, Issue:9 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Carbazoles; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Mice, Transgenic; Multiple Myeloma; Pyrroles	2006
Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis. Anti-cancer drugs, 2006, Volume: 17, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzamides; Blast Crisis; Cytarabine; Daunorubicin; Feasibility Studies; Harringtonines; Homoharringtonine; Humans; Imatinib Mesylate; In Vitro Techniques; Interferons; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oxides; Piperazines; Pyrimidines; Vincristine	2006
Chronic myeloid leukemia as a secondary malignancy after ALK-positive anaplastic large cell lymphoma. Human pathology, 2007, Volume: 38, Issue:10 Topics: Adolescent; Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Daunorubicin; Flow Cytometry; Fusion Proteins, bcr-abl; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Second Primary; Orbital Neoplasms; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Vincristine	2007
A dose intensive regimen of cytosine arabinoside and daunorubicin for chronic myelogenous leukemia in blast crisis. Leukemia research, 1995, Volume: 19, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged	1995
Differential induction of adult and fetal globin gene expression in the human CML cell subline KU-812F/33. Journal of biochemistry, 1994, Volume: 115, Issue:3 Topics: Azacitidine; Cell Differentiation; Daunorubicin; Drug Synergism; Electrophoresis, Polyacrylamide Gel; Erythrocytes; Fetal Hemoglobin; Globins; Hemin; Hemoglobins; Humans; Isoelectric Focusing; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Succinates; Succinic Acid; Tumor Cells, Cultured	1994
The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia. Experimental hematology, 1995, Volume: 23, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cell Division; Cells, Cultured; Colony-Forming Units Assay; Colony-Stimulating Factors; Daunorubicin; Female; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Hematopoietic Stem Cells; Heparin; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Recombinant Proteins	1995
Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells. Journal of cancer research and clinical oncology, 1995, Volume: 121, Issue:11 Topics: Apoptosis; Caffeine; Carboplatin; Cluster Analysis; Coloring Agents; Daunorubicin; Drug Resistance, Neoplasm; Flow Cytometry; G2 Phase; Gamma Rays; Gene Expression Regulation, Leukemic; Glutathione; GTP-Binding Proteins; HL-60 Cells; Humans; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Multivariate Analysis; Oncogene Proteins v-fos; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; ras Proteins; S Phase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53	1995
Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autolog Blood, 1995, Jun-01, Volume: 85, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Cell Survival; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Diploidy; Etoposide; Female; Genetic Markers; Hematopoietic Stem Cells; Humans; Idarubicin; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Mitoxantrone; Neoplastic Stem Cells; Philadelphia Chromosome; Remission Induction; Survival Rate; Vidarabine; Whole-Body Irradiation	1995
Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Separation; Cytarabine; Daunorubicin; Diploidy; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mitoxantrone; Remission Induction; Vidarabine	1995
Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia. Cytometry, 1994, Sep-01, Volume: 17, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blast Crisis; Child; Child, Preschool; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Treatment Failure; Tumor Cells, Cultured; Verapamil; Vinblastine; Vincristine	1994
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha. International journal of clinical & laboratory research, 1994, Volume: 24, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Child; Cytarabine; Daunorubicin; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Prednisone; Recombinant Proteins; Remission Induction; Vincristine	1994
Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11). Cancer genetics and cytogenetics, 1993, Jul-15, Volume: 68, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Chromosome Banding; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Daunorubicin; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Translocation, Genetic; Vincristine	1993
Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia. Acta haematologica, 1993, Volume: 89, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Combined Modality Therapy; Daunorubicin; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Recurrence; Remission Induction; Time Factors; Transplantation, Homologous; Vincristine	1993
Granulocytic sarcoma in patients with chronic myeloid leukaemia. JPMA. The Journal of the Pakistan Medical Association, 1995, Volume: 45, Issue:7 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Daunorubicin; Female; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Male; Middle Aged; Prognosis	1995
P170 glycoprotein expression and impaired anthracycline retention in chronic myeloid leukaemia. Leukemia & lymphoma, 1995, Volume: 17, Issue:3-4 Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Drug Resistance, Multiple; Flow Cytometry; Humans; Idarubicin; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase	1995
[Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:12 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Daunorubicin; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Prednisolone	1995
Increased activity and sensitivity of mitochondrial respiratory enzymes to tumor necrosis factor alpha-mediated inhibition is associated with increased cytotoxicity in drug-resistant leukemic cell lines. Blood, 1996, Mar-15, Volume: 87, Issue:6 Topics: Adenosine Diphosphate; Cell Death; Cells, Cultured; Daunorubicin; Depression, Chemical; Drug Resistance, Neoplasm; Electron Transport; Electron Transport Complex II; Electron Transport Complex IV; Enzyme Inhibitors; Free Radicals; Glycolysis; Humans; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitochondria; Multienzyme Complexes; NAD(P)H Dehydrogenase (Quinone); Neoplasm Proteins; Oxidoreductases; Paraquat; Succinate Dehydrogenase; Superoxides; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vinblastine	1996
The multidrug resistance phenotype confers immunological resistance. The Journal of experimental medicine, 1996, Jun-01, Volume: 183, Issue:6 Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clone Cells; Colchicine; Cytotoxicity, Immunologic; Daunorubicin; Drug Resistance, Multiple; Genetic Variation; HL-60 Cells; Humans; Immunoglobulin G; Immunoglobulin M; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phenotype; Tumor Cells, Cultured; Vincristine	1996
Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases. International journal of dermatology, 1997, Volume: 36, Issue:8 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Doxorubicin; Erythema; Female; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Recurrence	1997
Mobilization of hematopoietic progenitors in patients with chronic myeloid leukemia. Bone marrow transplantation, 1997, Volume: 20, Issue:10 Topics: Adult; Clone Cells; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Female; Filgrastim; Fusion Proteins, bcr-abl; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; In Situ Hybridization, Fluorescence; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Polymerase Chain Reaction; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Tumor Stem Cell Assay	1997
Mobilization of Philadelphia-negative peripheral blood progenitor cells with chemotherapy and rhuG-CSF in chronic myelogenous leukaemia patients with a poor response to interferon-alpha. British journal of haematology, 1998, Volume: 101, Issue:1 Topics: Adjuvants, Immunologic; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Interferon-alpha; Lenograstim; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Male; Middle Aged; Recombinant Proteins; Treatment Outcome	1998
Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML. Advances in experimental medicine and biology, 1999, Volume: 457 Topics: Acridines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow; Cell Survival; Cyclosporine; Daunorubicin; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Recurrence; Tetrahydroisoquinolines; Tumor Cells, Cultured	1999
E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents. Cancer research, 2000, Jul-15, Volume: 60, Issue:14 Topics: Adenovirus E1A Proteins; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Caspase 3; Caspases; CDC2 Protein Kinase; Cell Cycle; Cell Division; Daunorubicin; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Flow Cytometry; Fusion Proteins, bcr-abl; Humans; K562 Cells; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luciferases; Microscopy, Phase-Contrast; Nucleic Acid Synthesis Inhibitors; Peptides; Plasmids; Poly(ADP-ribose) Polymerases; Transfection; Tumor Cells, Cultured	2000
Antiviral and antiproliferative activity in vitro of some new benzimidazole derivatives. Pharmacology & toxicology, 2001, Volume: 88, Issue:2 Topics: Animals; Antineoplastic Agents; Antiviral Agents; Benzimidazoles; Burkitt Lymphoma; Cell Division; Chlorocebus aethiops; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterovirus B, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Vero Cells; Viruses	2001
Resistance to daunorubicin-induced apoptosis is not completely reversed in CML blast cells by STI571. Leukemia, 2002, Volume: 16, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Nucleus; Daunorubicin; DNA Fragmentation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potentials; Mitochondria; Phosphatidylserines; Piperazines; Pyrimidines; Tumor Cells, Cultured	2002
Cytomegalovirus infection in children with blood diseases. Acta haematologica Polonica, 1992, Volume: 23, Issue:3 Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Daunorubicin; Female; gamma-Globulins; Humans; Immune Tolerance; Immunization, Passive; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Thioguanine; Vincristine	1992
[Treatment of leukemia: discussion]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1992, Jul-10, Volume: 81, Issue:7 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Granulocyte Colony-Stimulating Factor; Hematologic Tests; Humans; L-Lactate Dehydrogenase; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mercaptopurine; Prednisolone; Remission Induction	1992
Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon. Cancer genetics and cytogenetics, 1992, Volume: 58, Issue:2 Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marrow; Chromosome Aberrations; Chromosome Banding; Daunorubicin; Gene Rearrangement; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Prednisolone; Remission Induction; Vincristine	1992
[Allogeneic bone marrow transplantation in the treatment of leukemia: analysis of 10 cases]. Zhonghua nei ke za zhi, 1991, Volume: 30, Issue:7 Topics: Adolescent; Adult; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Whole-Body Irradiation	1991
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Diseases; Cytarabine; Daunorubicin; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Middle Aged; Prognosis; Remission Induction; Survival Analysis	1992
Intensive chemotherapy induction followed by interferon-alpha maintenance in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Cancer, 1991, Sep-15, Volume: 68, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Drug Resistance; Female; Follow-Up Studies; Humans; Interferon Type I; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Pilot Projects; Prednisone; Survival Rate; Vincristine	1991
3'-Deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin conquers multidrug resistance by rapid influx following higher frequency of formation of DNA single- and double-strand breaks. Cancer research, 1990, Aug-01, Volume: 50, Issue:15 Topics: Antibiotics, Antineoplastic; Biological Transport; Carubicin; Cell Line; Cell Nucleus; Cell Survival; Daunorubicin; DNA Damage; DNA Topoisomerases, Type II; DNA, Neoplasm; DNA, Single-Stranded; Doxorubicin; Drug Resistance; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Tumor Cells, Cultured	1990
[The uptake of daunorubicin, adriamycin and aclarubicin into leukemic cells measured by flow cytometry]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:5 Topics: Aclarubicin; Daunorubicin; Doxorubicin; Flow Cytometry; Humans; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Tumor Cells, Cultured	1990
Juvenile chronic myelocytic leukemia: experience with intensive combination chemotherapy. Medical and pediatric oncology, 1990, Volume: 18, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Daunorubicin; Discriminant Analysis; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Recurrence; Survival Rate	1990
Daunomycin, cytosin-arabinoside and VP-16 (DAV) for myeloid blast crisis of CML. Blut, 1989, Volume: 58, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Philadelphia Chromosome; Thioguanine	1989